16hon MSN
Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.
Moderna is one of the hottest stocks of the year because of its custom cancer treatment. Full Phase 3 data are set to be ...
This company made headlines with its coronavirus vaccine.
The latest trading day saw Moderna (MRNA) settling at $245.81, representing a +1.54% change from its previous close.
Moderna shares rose ahead of late-stage clinical trial results for intismeran autogene.The companies are preparing regulatory ...
Profit taking is hitting one of biotech’s hottest trades, and the selling is landing heaviest on the stock that ran the ...
Few large biotech stocks have rewarded patience like Moderna (NASDAQ:MRNA | MRNA Price Prediction), and the size of that run now raises a hard question about what comes next. Moderna stock is up 545% ...
Stephen Hoge and Dean Li, at the STAT Summit, spoke of how Merck and Moderna will pair Keytruda with personalized mRNA ...
Moderna and Merck prepare FDA submission for their individualized mRNA melanoma vaccine.The company reported an annual ...
CAMBRIDGE, MA / ACCESS Newswire / October 13, 2026 / (NASDAQ:MRNA), today announced that it will host a live conference call ...
Moderna Inc. (NASDAQ: MRNA) has delivered an extraordinary performance in 2026, transforming from a heavily scrutinized ...
Moderna (MRNA) stock surged 14% after reports of a new NIH cancer research initiative and encouraging trial data with Merck.
Moderna, Inc. (NASDAQ:MRNA) traded at around $196 on October 7, up 4.81% on the day and 571.42% higher over twelve months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results